Moderna Is Up 500% in 12 Months. Can It Keep Going?
Moderna’s COVID-19 vaccine technology has rewarded investors with serious gains. What’s next for the stock?
Mindfully Curated
Moderna’s COVID-19 vaccine technology has rewarded investors with serious gains. What’s next for the stock?
Maybe, but there were even more important considerations.
Kinsale Capital focuses exclusively on excess and surplus insurance lines, offering investors a unique pure-play option in a highly fragmented market.
Successful money managers generally avoided Dow stocks in the preceding quarter — but these three were the exception.
It’s not like the other vaccine makers.
And there’s more than just dividends to like with these big pharma stocks.
Analysts’ high-water price targets foresee these fast-growing stocks doubling or tripling in value.
It boils down to which company’s clinical trial results look better for treating Alzheimer’s at the moment.
It depends, but you’ll be banking notably more than the average retiree.
Workers in their 40s and 50s have funds socked away for the future. But do they have enough?
LCI earnings call for the period ending June 30, 2021.
With the right strategy, you can maximize your benefits.
ESTC earnings call for the period ending June 30, 2021.
AMSWA earnings call for the period ending June 30, 2021.
CRM earnings call for the period ending June 30, 2021.
ULTA earnings call for the period ending June 30, 2021.
LX earnings call for the period ending June 30, 2021.
WSM earnings call for the period ending June 30, 2021.
VIOT earnings call for the period ending June 30, 2021.
UCL earnings call for the period ending June 30, 2021.